Glucose Monitoring Device Market 2020 Insights, Potential Business Strategies, Mergers and Acquisitions, Revenue Analysis to 2025|MRE

New York, March 17, 2020: The growing incidence of diabetes and rising awareness about the self-administration of diabetes is filling the development of the global glucose monitoring devices market. The presentation of therapeutic gadgets that are perfect with cell phones and shrewd devices is putting forth simple access to these gadgets to an expansive number of end-clients in the global market. The incorporation glucose monitoring devices with mobile applications has facilitated the monitoring of blood glucose levels among patients.

The Glucose Monitoring Device Market is expected to exceed more than US$ 6 Billion by 2024 at a CAGR of 6% in the given forecast period.

Browse Full Report From Here: https://www.marketresearchengine.com/glucose-monitoring-device-market

The scope of the report includes a detailed study of Glucose Monitoring Device Market with the reasons given for variations in the growth of the industry in certain regions.

The Glucose Monitoring Device Market is segmented on the lines of its technology, component, vehicle type and regional. On the basis of product segmentation it includes Diabetes monitoring devices and Insulin delivery devices. Based on application classification it covers Hospitals and Personal use. The Glucose Monitoring Device Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, and Rest of World. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche, DexCom, Johnson & Johnson, AstraZeneca, Insulet, Sanofi, Merck, GSK, Nova Biomedical, Becton Dickinson, Eli Lilly, Lupin, Braun, Takeda Pharmaceutical, Bayer HealthCare, Abbott Diabetes Care, Boehringer Ingelheim, Novo Nordisk, GlySens, Senseonics, Novartis, Omron Healthcare, Philips Healthcare, GE Healthcare, Medtronic and ResMed. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

This report provides:

1) An overview of the global market for Glucose Monitoring Device Market and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Glucose Monitoring Device Market
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

Reasons to Buy this Report:

1. Obtain the most up to date information available on all Glucose Monitoring Device Market.
2. Identify growth segments and opportunities in the industry.
3. Facilitate decision making on the basis of strong historic and forecast of Glucose Monitoring Device Market.
4. Assess your competitor's refining portfolio and its evolution.

The Glucose Monitoring Device Market has been segmented as below:

The Glucose Monitoring Device Market is segmented on the lines of Product, Application and Regional Analysis.

By Product this market is segmented on the basis of Diabetes monitoring devices and Insulin delivery devices. By Application this market is segmented on the basis of Hospitals and Personal use. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

The major driving factors of Glucose Monitoring Device Market are as follows:

o R&D and increasing technological innovations
o Growing prevalence of diabetes on a global level
o Rise in demand for point of care testing (POCT)

The major restraining factors of Glucose Monitoring Device Market are as follows:

o Stringent rules for glucose monitoring devices
o Standardisation and unfavourable reimbursement policies

The major opportunities of Glucose Monitoring Device Market are as follows:

o Improvements in the self-monitoring blood glucose (SMBG) devices
o Growth of emerging economies

Request Sample Report from here: https://bit.ly/2wfA8Kz

Table of Contents:

1. Introduction
1.1 Report Description
1.2 Markets Covered
1.3 Stakeholders
2. Research Methodology
3. Report Summary
4. Market Overview
5. Glucose Monitoring Device Market Analysis, By Product
6. Glucose Monitoring Device Market Analysis, By Application
7. Glucose Monitoring Device Market Analysis, By Region
8. Competitive Overview
9. Company Profiles
9.1 Roche
9.2 DexCom
9.3 Johnson & Johnson
9.4 GSK
9.5 Nova Biomedical
9.6 Becton Dickinson
9.7 Eli Lilly
9.8 Merck
9.9 Takeda Pharmaceutical
9.10 Bayer HealthCare
9.11 Abbott Diabetes Care
9.12 Boehringer Ingelheim
9.13 Insulet
9.14 Sanofi
9.15 Novo Nordisk
9.16 GlySens
9.17 Senseonics
9.18 Braun
9.19 AstraZeneca
9.20 Omron Healthcare
9.21 Philips Healthcare
9.22 GE Healthcare
9.23 Medtronic
9.24 ResMed
9.25 Novartis
9.26 Lupin

Media Contact
Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

This release was published on openPR.